EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, iRhythm Technologies's enterprise value is $3,247.6 Mil.
iRhythm Technologies's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was $-100.1 Mil. Therefore, iRhythm Technologies's EV-to-EBITDA for today is -32.43.
The historical rank and industry rank for iRhythm Technologies's EV-to-EBITDA or its related term are showing as below:
IRTC'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -243.63 Med: -44.57 Max: -25.77
Current: -32.43
During the past 10 years, the highest EV-to-EBITDA of iRhythm Technologies was -25.77. The lowest was -243.63. And the median was -44.57.
IRTC's EV-to-EBITDA is ranked worse than 100% of 483
companies
in the Medical Devices & Instruments industry
Industry Median: 16.47
vs IRTC: -32.43
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
iRhythm Technologies EV-to-EBITDA Historical Data
The historical data trend for iRhythm Technologies's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of iRhythm Technologies's EV-to-EBITDA
For the Medical Devices subindustry, iRhythm Technologies's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
iRhythm Technologies's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, iRhythm Technologies's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where iRhythm Technologies's EV-to-EBITDA falls into.
iRhythm Technologies's current Enterprise Value is $3,247.6 Mil.
iRhythm Technologies's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-100.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
iRhythm Technologies's PE Ratio for today is calculated as:
iRhythm Technologies's share price for today is $99.01.
iRhythm Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.230.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of iRhythm Technologies's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
iRhythm Technologies (iRhythm Technologies) Business Description
iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities. The company's portfolio include ambulatory cardiac monitoring services on a platform, called the Zio service, which combines an easy-to-wear and unobtrusive biosensor that can be worn for up to 14 consecutive days with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company derived its revenue from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
IRTC has been successfully added to your 